TRAVIS HUNTER: Open Payments
NPI 1114153137 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 39 payments from 13 companies in 2025. Trend: 2023 $711 · 2024 $399 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $177 |
| ABBVIE INC. | 11 | $155 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, Qelbree, INGREZZA, TRINTELLIX, FANAPT, ABILIFY ASIMTUFII.
Industry payments across UT — which companies pay providers there.
